Silicon Labs Announces First Quarter 2014 Results

AUSTIN, Texas--(BUSINESS WIRE)--

Silicon Labs SLAB, a leader in high-performance, analog-intensive, mixed-signal integrated circuits (ICs), today reported financial results for its first quarter ended March 29, 2014. Revenue in the first quarter was at the top end of guidance at $145.7 million, compared with $146.2 million reported in the fourth quarter. Additionally, the company reported excellent performance on its balance sheet with strong cash flows and effective working capital management.

Q1 Financial Highlights

On a GAAP basis:

• Gross margin was 59.8 percent
• R&D expenses were $42.5 million
• SG&A expenses were $34.6 million
• Operating income as a percentage of revenue was 6.9 percent
• Diluted earnings per share were $0.18

On a non-GAAP basis (results exclude the impact of stock compensation, amortization from acquired intangible assets and certain other items as set forth in the reconciliation tables below):

• Gross margin was 60.2 percent
• R&D expenses were $35.0 million
• SG&A expenses were $28.5 million
• Operating income was 16.6 percent
• Diluted earnings per share were $0.42

Business Highlights

• Broad-based revenue was $72.3 million, essentially flat sequentially, as expected.
• Broadcast exceeded expectations with revenue of $50.7 million, including record revenue in video.
• Access revenue decreased slightly, as expected, to $22.7 million.

Product Highlights

• Introduced a new version of the Simplicity Studio™ development ecosystem supporting Silicon Labs' MCU products in a single, unified platform, making the embedded design process easier, faster and more efficient.
• Announced the expansion of Silicon Labs' Ember® ZigBee® portfolio with the introduction of a new ARM®-based system-on-a-chip family that reduces the cost and complexity of deploying ZigBee solutions in smart metering and home automation applications.
• Launched the industry's first single-chip digital ultraviolet (UV) index sensor ICs designed to track UV sun exposure, heart rate and blood oxygen levels for wearable products such as smart watches and health and fitness trackers.
• Acquired the full product portfolio and intellectual property of Silicon Valley-based Touchstone Semiconductor, an early-stage technology company and provider of low-power analog IC products targeting Internet of Things applications.

Business Outlook

The company expects revenue in the second quarter to be in the range of $147 million to $151 million. Second quarter diluted earnings per share are expected to be between $0.15 and $0.19 on a GAAP basis and between $0.43 and $0.47 on a non-GAAP basis. Both GAAP and non-GAAP estimates include an estimated $0.03 per share effect from litigation costs.

“We continue to strengthen our position as a leading supplier of silicon solutions for the Internet of Things,” said Tyson Tuttle, CEO of Silicon Labs. “We expect this momentum to drive record Broad-based revenue in the second quarter.”

Webcast and Conference Call

A conference call discussing the quarterly results will follow this press release at 7:30 a.m. Central time. An audio webcast will be available simultaneously on Silicon Labs' website under Investor Relations (www.silabs.com). A replay will be available after the call at the same website listed above or by calling 1 (855) 859-2056 or (404) 537-3406 (international) and by entering 39717388. The replay will be available through May 29.

About Silicon Labs

Silicon Labs is an industry leader in the innovation of high-performance, analog-intensive, mixed-signal ICs. Developed by a world-class engineering team with unsurpassed expertise in mixed-signal design, Silicon Labs' diverse portfolio of patented semiconductor solutions offers customers significant advantages in performance, size and power consumption. For more information about Silicon Labs, please visit www.silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs' current expectations. The words "believe," "estimate," "expect," "intend," "anticipate," "plan," "project," "will" and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; dependence on a limited number of products and customers; intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing our distributors, manufacturers and subcontractors; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with our accounts receivable; dependence on key personnel; stock price volatility; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs' business and results of operations to risks of natural disasters, epidemics, war and political unrest; debt-related risks; capital-raising risks; the competitive and cyclical nature of the semiconductor industry; average selling prices of products may decrease significantly and rapidly; information technology risks; conflict mineral risks and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the Silicon Labs logo, Simplicity Studio and Ember are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Silicon Laboratories Inc.
Condensed Consolidated Statements of Income
(In thousands, except per share data)
(Unaudited)
			Three Months Ended
			March 29, 2014				March 30, 2013
Revenues			$	145,691			$	145,375
Cost of revenues				58,586				58,003
Gross margin				87,105				87,372
Operating expenses:
Research and development				42,485				37,582
Selling, general and administrative				34,611				29,153
Operating expenses				77,096				66,735
Operating income				10,009				20,637
Other income (expense):
Interest income				302				335
Interest expense				(798	)			(842	)
Other income (expense), net				67				(52	)
Income before income taxes				9,580				20,078
Provision for income taxes				1,470				44
Net income			$	8,110			$	20,034
Earnings per share:
Basic			$	0.19			$	0.47
Diluted			$	0.18			$	0.46
Weighted-average common shares outstanding:
Basic				43,081				42,186
Diluted				44,056				43,110

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures
(In thousands, except per share data)
Non-GAAP Income Statement Items		Three Months Ended March 29, 2014
		GAAP Measure			GAAP Percent of Revenue				Stock Compensation Expense			Intangible Asset Amortization			Termination Costs				Acquisition Related Items			Non-GAAP Measure				Non- GAAP Percent of Revenue
Revenues		$	145,691
Gross margin			87,105			59.8	%		$	195		$	390		$	--			$	--		$	87,690				60.2	%
Research and development			42,485			29.2	%			4,241			3,247			--				--			34,997				24.0	%
Selling, general and administrative			34,611			23.7	%			4,841			729			(267	)			816			28,492				19.6	%
Operating income			10,009			6.9	%			9,277			4,366			(267	)			816			24,201				16.6	%
Non-GAAP Diluted Earnings Per Share					Three Months Ended March 29, 2014
					GAAP Measure				Stock Compensation Expense			Intangible Asset Amortization			Termination Costs				Acquisition Related Items			Release of Unrecognized Tax Benefits				Non- GAAP Measure
Net income					$	8,110			$	7,966		$	3,019		$	(199	)		$	816		$	(1,292	)		$	18,420
Diluted shares outstanding						44,056				--			--			--				--			--				44,056
Diluted earnings per share					$	0.18																				$	0.42

Unaudited Forward-Looking Statements Regarding Business Outlook
(In thousands, except per share information)

Business Outlook		Three Months Ending June 28, 2014
		High			Low
Estimated GAAP diluted earnings per share		$	0.19		$	0.15
Estimated non-GAAP charges			0.28			0.28
Estimated non-GAAP diluted earnings per share		$	0.47		$	0.43

Silicon Laboratories Inc.
Condensed Consolidated Balance Sheets
(In thousands, except per share data)
(Unaudited)
			March 29, 2014				December 28, 2013
Assets
Current assets:
Cash and cash equivalents			$	128,323			$	95,800
Short-term investments				194,765				179,593
Accounts receivable, net of allowances for doubtful accounts of $767 at March 29, 2014 and $797 at December 28, 2013				64,672				72,124
Inventories				44,334				45,271
Deferred income taxes				15,203				18,878
Prepaid expenses and other current assets				40,214				47,651
Total current assets				487,511				459,317
Long-term investments				10,997				10,632
Property and equipment, net				130,829				132,445
Goodwill				228,781				228,781
Other intangible assets, net				128,453				131,593
Other assets, net				23,482				28,382
Total assets			$	1,010,053			$	991,150
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable			$	22,707			$	22,126
Current portion of long-term debt				8,750				7,500
Accrued expenses				67,745				45,975
Deferred income on shipments to distributors				32,589				30,853
Income taxes				1,330				2,693
Total current liabilities				133,121				109,147
Long-term debt				85,000				87,500
Other non-current liabilities				30,737				55,941
Total liabilities				248,858				252,588
Commitments and contingencies
Stockholders' equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding				--				--
Common stock – $0.0001 par value; 250,000 shares authorized; 43,433 and 42,779 shares issued and outstanding at March 29, 2014 and December 28, 2013, respectively				4				4
Additional paid-in capital				62,883				48,630
Retained earnings				698,722				690,612
Accumulated other comprehensive loss				(414	)			(684	)
Total stockholders' equity				761,195				738,562
Total liabilities and stockholders' equity			$	1,010,053			$	991,150

Silicon Laboratories Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
			Three Months Ended
			March 29, 2014				March 30, 2013
Operating Activities
Net income			$	8,110			$	20,034
Adjustments to reconcile net income to cash provided by operating activities:
Depreciation of property and equipment				3,290				3,297
Amortization of other intangible assets and other assets				4,491				2,840
Stock-based compensation expense				9,277				6,260
Income tax benefit (shortfall) from stock-based awards				45				(363	)
Excess income tax benefit from stock-based awards				(235	)			(217	)
Deferred income taxes				6,784				7,521
Changes in operating assets and liabilities:
Accounts receivable				7,452				5,256
Inventories				1,083				(7,350	)
Prepaid expenses and other assets				14,266				4,620
Accounts payable				1,195				2,356
Accrued expenses				(2,218	)			(4,330	)
Deferred income on shipments to distributors				1,736				(598	)
Income taxes				(8,324	)			(9,818	)
Net cash provided by operating activities				46,952				29,508
Investing Activities
Purchases of available-for-sale investments				(43,366	)			(78,851	)
Proceeds from sales and maturities of available-for-sale investments				28,242				25,674
Purchases of property and equipment				(1,673	)			(3,898	)
Purchases of other assets				(2,113	)			(1,228	)
Net cash used in investing activities				(18,910	)			(58,303	)
Financing Activities
Proceeds from issuance of common stock, net of shares withheld for taxes				5,496				4,915
Excess income tax benefit from stock-based awards				235				217
Payments on debt				(1,250	)			(2,500	)
Net cash provided by financing activities				4,481				2,632
Increase (decrease) in cash and cash equivalents				32,523				(26,163	)
Cash and cash equivalents at beginning of period				95,800				105,426
Cash and cash equivalents at end of period			$	128,323			$	79,263